Financial Gravity Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1
| Closed | -$397 | – | 2548 |
|
|
2024
Q1 | $397 | Sell |
1
-1
| -50% | -$397 | ﹤0.01% | 1433 |
|
|
2023
Q4 | $916 | Buy |
2
+1
| +100% | +$458 | ﹤0.01% | 1054 |
|
|
2023
Q3 | $436 | Sell |
1
-381
| -100% | -$166K | ﹤0.01% | 829 |
|
|
2023
Q2 | $1.04K | Buy |
382
+36
| +10% | +$98 | ﹤0.01% | 802 |
|
|
2023
Q1 | $473 | Buy |
+346
| New | +$473 | 0.01% | 453 |
|
|
2022
Q4 | – | Sell |
-738
| Closed | -$335 | – | 1540 |
|
|
2022
Q3 | $335 | Sell |
738
-168
| -19% | -$76 | 0.01% | 456 |
|
|
2022
Q2 | $413 | Sell |
906
-327
| -27% | -$149 | 0.01% | 411 |
|
|
2022
Q1 | $560 | Sell |
1,233
-10,492
| -89% | -$4.77K | 0.02% | 398 |
|
|
2021
Q4 | $3.7K | Buy |
11,725
+11,724
| +1,172,400% | +$3.7K | 0.08% | 233 |
|
|
2021
Q3 | $425K | Hold |
1
| – | – | 0.2% | 92 |
|
|
2021
Q2 | $359K | Hold |
1
| – | – | 0.13% | 110 |
|
|
2021
Q1 | $384 | Sell |
1
-7
| -88% | -$2.69K | 0.01% | 409 |
|
|
2020
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 354 |
|
|
2020
Q2 | – | Sell |
-67
| Closed | -$10.2K | – | 943 |
|
|
2020
Q1 | $10.2K | Sell |
67
-63
| -48% | -$9.57K | 0.03% | 205 |
|
|
2019
Q4 | $150K | Sell |
130
-104
| -44% | -$120K | 0.1% | 185 |
|
|
2019
Q3 | $33K | Sell |
234
-757
| -76% | -$107K | 0.03% | 368 |
|
|
2019
Q2 | $124K | Buy |
991
+768
| +344% | +$96.1K | 0.1% | 204 |
|
|
2019
Q1 | $25K | Buy |
+223
| New | +$25K | 0.02% | 409 |
|
|
2018
Q3 | $42K | Sell |
418
-17
| -4% | -$1.71K | 0.04% | 371 |
|
|
2018
Q2 | $50K | Buy |
+435
| New | +$50K | 0.05% | 326 |
|